Association of Plasma γ′ Fibrinogen with Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 12, 2015, Pages 2700-2706

  Appiah, Duke ^a   Schreiner, Pamela J ^a   MacLehose, Richard F ^a   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiovascular; coronary disease diseases; epidemiology; fibrinogen; thrombosis

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; FIBRINOGEN; FIBRINOGEN GAMMA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; FIBRINOGEN GAMMA'; FIBRINOGEN VARIANT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSESSMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEART DEATH; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SMOKING; SPORT; SYSTOLIC BLOOD PRESSURE; AGED; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; CORONARY DISEASE; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STROKE; TIME FACTOR; UNITED STATES;

AGED; ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; FIBRINOGENS, ABNORMAL; HEART FAILURE; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; UNITED STATES;

EID: 84948088520     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306284     Document Type: Article

References (28)

1. Danesh J, Lewington S, Thompson SG, et al; Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant metaanalysis. JAMA. 2005;294:1799-1809.
2. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1997;96:1102-1108.
3. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) study investigators. Circulation. 1999;100:736-742.
4. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE, D'Agostino RB Sr. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation. 2000;102:1634-1638.
5. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, Delépine M, Lathrop M, Peto R, Collins R. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Int J Epidemiol. 2006;35:935-943. doi: 10.1093/ije/dyl114.
6. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb. 1992;12:780-788.
7. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 1991;91:191-205.
8. Lovely RS, Kazmierczak SC, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Farrell DH. Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clin Chem. 2010;56:781-788. doi: 10.1373/clinchem.2009.138347.
9. Farrell DH. ' fibrinogen as a novel marker of thrombotic disease. Clin Chem Lab Med. 2012;50:1903-1909. doi: 10.1515/cclm-2012-0005.
10. Kim PY, Stewart RJ, Lipson SM, Nesheim ME. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease. J Thromb Haemost. 2007;5:1250-1256. doi: 10.1111/j.1538-7836.2007.02426.x.
11. Drouet L, Paolucci F, Pasqualini N, Laprade M, Ripoll L, Mazoyer E, Bal dit Sollier C, Vanhove N. Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor Blood Coagul Fibrinolysis. 1999;10(suppl 1):S35-S39.
12. Lovely RS, Falls LA, Al-Mondhiry HA, Chambers CE, Sexton GJ, Ni H, Farrell DH. Association of gammaA/gamma' fibrinogen levels and coronary artery disease. Thromb Haemost. 2002;88:26-31.
13. Mannila MN, Lovely RS, Kazmierczak SC, Eriksson P, Samnegård A, Farrell DH, Hamsten A, Silveira A. Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost. 2007;5:766-773. doi: 10.1111/j.1538-7836.2007.02406.x.
14. Lovely RS, Yang Q, Massaro JM, Wang J, D'Agostino RB Sr, O'Donnell CJ, Shannon J, Farrell DH. Assessment of genetic determinants of the association of ' fibrinogen in relation to cardiovascular disease. Arterioscler Thromb Vasc Biol. 2011;31:2345-2352. doi: 10.1161/ATVBAHA.111.232710.
15. Cheung EY, Uitte de Willige S, Vos HL, Leebeek FW, Dippel DW, Bertina RM, de Maat MP. Fibrinogen gamma' in ischemic stroke: a case-control study. Stroke. 2008;39:1033-1035. doi: 10.1161/STROKEAHA.107.495499.
16. Uitte de Willige S, Standeven KF, Philippou H, Ariens RA. The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood. 2009;114:3994-4001.
17. Walton BL, Getz TM, Bergmeier W, Lin FC, Uitte de Willige S, Wolberg AS. The fibrinogen A/' isoform does not promote acute arterial thrombosis in mice. J Thromb Haemost. 2014;12:680-689. doi: 10.1111/jth.12534.
18. Mosesson MW. Update on antithrombin I (fibrin). Thromb Haemost. 2007;98:105-108.
19. Cooper AV, Standeven KF, Ariëns RA. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood. 2003;102:535-540. doi: 10.1182/blood-2002-10-3150.
20. Lovely RS, Rein CM, White TC, Jouihan SA, Boshkov LK, Bakke AC, McCarty OJ, Farrell DH. gammaA/gamma' fibrinogen inhibits thrombininduced platelet aggregation. Thromb Haemost. 2008;100:837-846.
21. Lovely RS, Boshkov LK, Marzec UM, Hanson SR, Farrell DH. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway. Br J Haematol. 2007;139:494-503. doi: 10.1111/j.1365-2141.2007.06825.x.
22. Mosesson MW, Hernandez I, Raife TJ, Medved L, Yakovlev S, Simpson-Haidaris PJ, Uitte de Willige S, Bertina RM. Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost. 2007;5:62-69. doi: 10.1111/j.1538-7836.2006.02270.x.
23. Alexander KS, Madden TE, Farrell DH. Association between ' fibrinogen levels and inflammation. Thromb Haemost. 2011;105:605-609. doi: 10.1160/TH10-09-0626.
24. Rein-Smith CM, Anderson NW, Farrell DH. Differential regulation of fibrinogen chain splice isoforms by interleukin-6. Thromb Res. 2013;131:89-93. doi: 10.1016/j.thromres.2012.09.017.
25. Kotzé RC, Ariëns RA, de Lange Z, Pieters M. CVD risk factors are related to plasma fibrin clot properties independent of total and or ' fibrinogen concentration. Thromb Res. 2014;134:963-969. doi: 10.1016/j. thromres.2014.08.018.
26. Cheung EY, Vos HL, Kruip MJ, den Hertog HM, Jukema JW, de Maat MP. Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood. 2009;114:4603-4604. doi: 10.1182/blood-2009-08-236240.
27. van den Herik EG, Cheung EY, de Lau LM, den Hertog HM, Leebeek FW, Dippel DW, Koudstaal PJ, de Maat MP. '/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke. Thromb Haemost. 2011;105:430-434. doi: 10.1160/TH10-09-0569.
28. Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G, Chambless LE. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail. 2012;5:152-159. doi: 10.1161/CIRCHEARTFAILURE.111.963199.